Falls and Fractures in Patients with Parkinson’s Disease-Related Psychosis Treated with Pimavanserin vs Atypical Antipsychotics: A Cohort Study

BACKGROUND: Parkinson’s disease-related psychosis increases patients’ risk of falls. Pimavanserin is an atypical antipsychotic approved in the USA in 2016 for the treatment of hallucinations and delusions associated with Parkinson’s disease-related psychosis. OBJECTIVE: We aimed to compare the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Layton, J. Bradley, Forns, Joan, Turner, Mary Ellen, Dempsey, Colleen, Bartsch, Jennifer L., Anthony, Mary S., Danysh, Heather E., Ritchey, Mary E., Demos, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844331/
https://www.ncbi.nlm.nih.gov/pubmed/34718963
http://dx.doi.org/10.1007/s40801-021-00284-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844331/
https://www.ncbi.nlm.nih.gov/pubmed/34718963
http://dx.doi.org/10.1007/s40801-021-00284-1

Ejemplares similares